IP Library Granted Patent US 8,267,905
Granted Patent B2
US 8,267,905 · App. 11/414,543 · Granted Sep 18, 2012

Apparatus and method for delivery of therapeutic and other types of agents

Assignee: NeuroSystec Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,267,905
App. No.
11/414,543
Granted
Sep 18, 2012
Kind
B2
Abstract

Implantable drug delivery systems target delivery of small volumes of drugs to specific tissues. In some cases, a drug delivery system includes an implantable osmotic pump connected to a drug-containing housing, with that housing connected to a needle, cochlear implant or other type of component for ultimate delivery to the target tissue. In some implementations, a subcutaneous port receives a fluid from an external pump. The port is connected to a needle or other component for delivery of one or more drugs to the target tissue. Both solid and liquid drug formulations can be used. In embodiments using solid drugs, a separate drug vehicle (such as saline) can be used to dissolve a portion of the solid drug, with the drug-loaded vehicle then delivered to the target tissue.

Claims (14)

1. An apparatus for delivery of one or more drugs to a target tissue, comprising:

a subcutaneously-implantable osmotic pump having an outlet;

a subcutaneously-implantable housing having an inlet in fluid communication with the pump outlet, an internal cavity in fluid communication with the inlet and containing one or more solid drugs, and an outlet in fluid communication with the cavity, wherein the housing further includes first and second sections, and wherein the first and second sections are non-destructively removable from one another to expose the cavity;

a catheter having a lumen in fluid communication with the housing outlet; and

a terminal component in fluid communication with the catheter lumen and configured for implantation in the target tissue, wherein the terminal component comprises a bone needle configured for insertion through a bone into the cochlea of a human implantee and being bent so as to allow complete implantation below the skin of the implantee, the bone needle further including an insertion stop formed from a biocompatible porous material configured for integration into the bone of the implantee.

2. The apparatus of claim 1 , wherein the housing is non-destructively removable from the pump.

3. The apparatus of claim 2 , wherein the pump outlet and housing inlet are connected by a second catheter.

4. The apparatus of claim 1 , wherein the housing further includes an antibacterial filter positioned in a fluid path between the one or more solid drugs and the housing outlet.

5. The apparatus of claim 1 , wherein the one or more solid drugs are contained within a removable cage located within the housing cavity.

6. The apparatus of claim 5 , wherein the housing further includes an antibacterial filter positioned in a fluid path between the one or more solid drugs and the housing outlet.

7. The apparatus of claim 1 , wherein the one or more solid drugs are contained within a non-removable cage located within the housing cavity.

8. The apparatus of claim 5 , wherein the one or more solid drugs contained within the removable cage are monolithic.

9. The apparatus of claim 5 , wherein the one or more solid drugs contained within the removable cage are in powder form.

10. The apparatus of claim 5 , wherein the one or more solid drugs contained within the removable cage are in the form of pellets.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2013
From: NEUROSYSTEC CORPORATION
To: INCUMED LLC
Reel/Frame 030552/0124 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2013
From: INCUMED, LLC
To: OTONOMY, INC.
Reel/Frame 030552/0582 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 12, 2006
From: LOBL, THOMAS J.; MCCORMACK, STEPHEN J.; NAGY, ANNA IMOLA; PANANEN, JACOB E.; SCHLOSS, JOHN V.
To: NEUROSYSTEC CORPORATION
Reel/Frame 017922/0271 →
Continuity (1)
Related Publication 20070255237A1 · Nov 1, 2007